Advertisement

Ads Placeholder
Loading...

Illumina, Inc.

ILMNNASDAQ
Healthcare
Medical - Diagnostics & Research
$127.38
$0.75(0.59%)
U.S. Market opens in 19h 20m

Illumina, Inc. (ILMN) Stock Overview

Explore Illumina, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap19.5B
P/E Ratio22.93
EPS (TTM)$5.45
ROE0.35%
Fundamental Analysis

AI Price Forecasts

1 Month$116.35
3 Months$80.27
1 Year Target$89.80

ILMN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Illumina, Inc. (ILMN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.27, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $89.80.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 22.93 and a market capitalization of 19.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.59%
5-Day Change
3.56%
1-Month Change
-1.68%
3-Month Change
-5.19%
6-Month Change
24.74%
Year-to-Date (YTD) Change
-5.19%
1-Year Change
66.68%
3-Year Change
-43.02%
5-Year Change
-65.91%
All-Time (Max) Change
569.36%

Contact Information

858 202 4500
5200 Illumina Way, San Diego, CA, 92122

Company Facts

89,700 Employees
IPO DateJul 28, 2000
CountryUS
Actively Trading

Frequently Asked Questions